<DOC>
	<DOCNO>NCT02815176</DOCNO>
	<brief_summary>Thrombotic biomarkers angiographic characteristic compare among de novo patient central serous chorioretinopathy ( CSC ) , polypoidal choroidal vasculopathy ( PCV ) control .</brief_summary>
	<brief_title>Angiographic Characteristics CSC , PCV Patients Thrombotic Bio-markers</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Plasminogen Activator Inhibitor 1</mesh_term>
	<mesh_term>Plasminogen Inactivators</mesh_term>
	<criteria>CSC neurosensory detachment optical coherence tomography ( OCT ) focal leakage fluorescein angiography ( FAG ) and/or late choroidal hyperpermeability indocyanine green angiography ( ICGA ) PCV subretinal and/or subretinal pigment epithelial fluid OCT branching vascular network and/or polyp ICGA Control epiretinal membrane ( ERM ) without underlie systemic , ophthalmic disease ERM Previous history use steroid ( oral , topical ) Previous history CSC/PCV Previous history evidence intraocular inflammation include uveitis Coexisting retinal choroidal diseases History allergic reaction fluorescein indocyanine green dye Underlying systemic condition could affect thrombotic profile ( e.g . diabetes , hypertension , metabolic syndrome , coronary artery disease , cerebrovascular disease , stroke , chronic renal failure , current smoker , pregnancy , sleep disorder )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Plasminogen activator inhibitor-1</keyword>
	<keyword>Wide angle fluorescein angiography</keyword>
	<keyword>Choroid</keyword>
</DOC>